Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Advanced Glycation End Products
100%
Microarchitecture
100%
Elderly Women
100%
Sclerostin
100%
Non-diabetic
40%
Gene Expression
30%
Runt-related Transcription Factor 2 (Runx2)
30%
Bone Microarchitecture
30%
Bone Formation
20%
Osteocalcin
20%
SOST Gene
20%
Femoral Head
10%
Collagen
10%
Bone Tissue
10%
Postmenopausal Women
10%
Fold Increase
10%
Bone Strength
10%
Bone Mineral Density
10%
Type 2 Diabetic
10%
Quinine
10%
Fracture Risk
10%
Biomechanical Properties
10%
Hip Surgery
10%
Osteocalcin Gene
10%
Bone-forming
10%
Density Property
10%
Glycated Hemoglobin A1c
10%
Bone Fragility
10%
Volumetric Bone Mineral Density (vBMD)
10%
Control Types
10%
Product Content
10%
Good Glycemic Control
10%
Low Bone Turnover
10%
Diabetic Women
10%
Bone Content
10%
Trabecular Separation
10%
Biochemistry, Genetics and Molecular Biology
Advanced Glycation End-Product
100%
Sclerostin
100%
RUNX2
42%
Osteocalcin
42%
Gene Expression
28%
Ossification
28%
Bone Density
28%
Downregulation
14%
Postmenopause
14%
Bone Turnover
14%
Glycemic Control
14%
Glycated Hemoglobin
14%
Neuroscience
Advanced Glycation End Product
100%
Sclerostin
100%
Diabetes Mellitus
42%
Osteocalcin
42%
RUNX2
42%
Gene Expression
28%
Body Mass Index
14%
Hemoglobin A1c
14%
Glycosylated Hemoglobin
14%
Immunology and Microbiology
Glycation
100%
Gene Expression
28%
Ossification
28%
Bone Density
28%
Hip
14%
Downregulation
14%
Bone Tissue
14%
Postmenopause
14%
Femoral Head
14%
Bone Turnover
14%
Glycemic Control
14%
Glycosylated Hemoglobin
14%